Program notes:

0:33 TAVR outcomes improved

1:33 Dapagliflozin 

2:33 Looked at comorbidities

3:00 Tolebrutinib for relapsing MS

4:00 Annualized relapse rate

5:00 Works in the CNS

6:00 First endpoint wasn't proven

6:20 Invasive group A strep

7:20 Become more resistant to antibiotics

8:01 Not a single type of group A strep

8:25 Hearing loss and heart failure

9:25 Psychological distress mediiates

10:25 With hearing aids, you would think it would go down

11:20 Everything looks associated

12:03 End